ATE293973T1 - Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria - Google Patents
Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malariaInfo
- Publication number
- ATE293973T1 ATE293973T1 AT95910230T AT95910230T ATE293973T1 AT E293973 T1 ATE293973 T1 AT E293973T1 AT 95910230 T AT95910230 T AT 95910230T AT 95910230 T AT95910230 T AT 95910230T AT E293973 T1 ATE293973 T1 AT E293973T1
- Authority
- AT
- Austria
- Prior art keywords
- antimalarial
- pharmaceutical compositions
- compositions containing
- alkaloids
- malaria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/195,547 US5639761A (en) | 1994-02-14 | 1994-02-14 | Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof |
PCT/US1995/001717 WO1995021616A1 (en) | 1994-02-14 | 1995-02-13 | Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE293973T1 true ATE293973T1 (de) | 2005-05-15 |
Family
ID=22721822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95910230T ATE293973T1 (de) | 1994-02-14 | 1995-02-13 | Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria |
Country Status (8)
Country | Link |
---|---|
US (2) | US5639761A (de) |
EP (1) | EP0741569B1 (de) |
JP (1) | JPH10501517A (de) |
AT (1) | ATE293973T1 (de) |
AU (1) | AU690967B2 (de) |
CA (1) | CA2183155C (de) |
DE (1) | DE69534177T2 (de) |
WO (1) | WO1995021616A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140339A (en) * | 1994-02-14 | 2000-10-31 | The United States Of America As Represented By The Department Of Health And Human Services | Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
US5639761A (en) | 1994-02-14 | 1997-06-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof |
US5578729A (en) * | 1994-07-22 | 1996-11-26 | The United States Of America As Represented By The Department Of Health And Human Services | Dimeric arylisoquinoline alkaloid compounds |
ES2197205T3 (es) * | 1994-07-22 | 2004-01-01 | The United States Of America, As Represented By The Secretary, Departm. Of Health And Human Services | Alcaloides monomericos y dimericos de naftilisoquinoleina y procedimiento de sintesis de los mismos. |
CH692321A5 (de) | 1997-11-03 | 2002-05-15 | Mepha Ag | Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält. |
US6143756A (en) * | 1998-05-15 | 2000-11-07 | National University Of Singapore | Antimalarial activity of β-carboline alkaloids |
US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
US7989491B2 (en) | 2003-02-12 | 2011-08-02 | Georgetown University | Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
US8188303B2 (en) | 2005-10-04 | 2012-05-29 | The Director General, Defence Research And Development Organisation | Anti-malarial compound isolated from Gomphostema niveum |
US8440695B2 (en) * | 2005-11-09 | 2013-05-14 | St Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
US9068993B2 (en) | 2010-11-04 | 2015-06-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Diagnostic assays and methods of use for detection of filarial infection |
HUE034721T2 (hu) * | 2011-08-25 | 2018-02-28 | St Jude Childrens Res Hospital | Szubsztituált 2-alkil-1-oxo-N-fenil-3-heteroaril-1,2,3,4-tetrahidroizokinolin-4-karboxamidok maláriaellenes terápiákhoz |
FR3108503A1 (fr) | 2020-03-24 | 2021-10-01 | Hermine Lanniel | Composition pharmaceutique active contre une infection virale du type coronavirus |
EP4251746A1 (de) | 2020-11-30 | 2023-10-04 | Cellectis SA | Verwendung von aminochinolinverbindungen zur höheren genintegration |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH541609A (de) | 1970-02-03 | 1973-09-15 | Ciba Geigy Ag | Verfahren zur Herstellung von Bi-isochinolinonen und deren Verwendung als Fluoreszenzfarbstoffe in Kunststoffen |
US4096190A (en) | 1976-11-26 | 1978-06-20 | Ici Americas Inc. | Oxidative coupling of alkylphenols catalyzed by metal ammonia complexes |
US5001115A (en) * | 1989-05-17 | 1991-03-19 | University Of Florida | Prodrugs of biologically active hydroxyaromatic compounds |
US5025020A (en) * | 1989-09-28 | 1991-06-18 | Cancer Biologics Of America, Inc. | Use of tetrandrine and its derivatives to treat malaria |
WO1992018125A1 (en) | 1991-04-12 | 1992-10-29 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Michellamines useful as antiviral agents, composition and method of treatment |
DE4117080A1 (de) * | 1991-05-25 | 1992-11-26 | Basf Ag | Anwendung von dioncophyllinen als fungizide |
EP0695294A1 (de) | 1993-04-19 | 1996-02-07 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Michellamine derivate nützlich als antivirale mittel |
US5578729A (en) | 1994-07-22 | 1996-11-26 | The United States Of America As Represented By The Department Of Health And Human Services | Dimeric arylisoquinoline alkaloid compounds |
US5571919A (en) | 1994-07-22 | 1996-11-05 | The United States Of America As Represented By The Department Of Health And Human Services | Dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
US5639761A (en) | 1994-02-14 | 1997-06-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof |
US5552550A (en) | 1994-07-22 | 1996-09-03 | The United States Of America, As Represented By The Department Of Health And Human Services | Monomeric Naphthylisoquinoline alkaloids and synthesis methods thereof |
US5409938A (en) | 1994-02-14 | 1995-04-25 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof |
-
1994
- 1994-02-14 US US08/195,547 patent/US5639761A/en not_active Expired - Lifetime
-
1995
- 1995-02-13 DE DE69534177T patent/DE69534177T2/de not_active Expired - Fee Related
- 1995-02-13 JP JP7521360A patent/JPH10501517A/ja active Pending
- 1995-02-13 AT AT95910230T patent/ATE293973T1/de not_active IP Right Cessation
- 1995-02-13 AU AU18417/95A patent/AU690967B2/en not_active Ceased
- 1995-02-13 CA CA002183155A patent/CA2183155C/en not_active Expired - Fee Related
- 1995-02-13 EP EP95910230A patent/EP0741569B1/de not_active Expired - Lifetime
- 1995-02-13 WO PCT/US1995/001717 patent/WO1995021616A1/en active IP Right Grant
-
1997
- 1997-04-16 US US08/843,582 patent/US6627641B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10501517A (ja) | 1998-02-10 |
EP0741569B1 (de) | 2005-04-27 |
AU690967B2 (en) | 1998-05-07 |
CA2183155C (en) | 2003-09-09 |
DE69534177D1 (de) | 2005-06-02 |
WO1995021616A1 (en) | 1995-08-17 |
US6627641B1 (en) | 2003-09-30 |
EP0741569A1 (de) | 1996-11-13 |
AU1841795A (en) | 1995-08-29 |
DE69534177T2 (de) | 2006-03-09 |
CA2183155A1 (en) | 1995-08-17 |
US5639761A (en) | 1997-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE293973T1 (de) | Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria | |
DE69837809D1 (de) | Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen | |
DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
DE60025812D1 (de) | Jak-3 hemmer zur behandlung von allergischen störungen | |
ATE265857T1 (de) | Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
TR199903331T2 (xx) | Farnesil protein transferas engelleyicileri. | |
DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
ATE322265T1 (de) | Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält | |
YU21401A (sh) | Tetrahidropiridoetri | |
DE69805973D1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase | |
CY1118924T1 (el) | Μεθοδος για θεραπεια της πρωτοπαθους αϋπνιας | |
ATE508114T1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
NO177785C (no) | Analogifremgangsmåter for fremstilling av terapeutisk aktive alkoksy-4(1H)-pyridonderivater | |
ATE293971T1 (de) | Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
ES2162110T3 (es) | Derivados de la quinolina antimalaria. | |
DE69635614D1 (de) | Verwendung von brefeldin a und deren derivate in der herstellung von arzneimittel zur behandlung von hyperplasie und verwandten erkrankungen | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
ATE264309T1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
CA2183247A1 (en) | Antimalarial Korupensamines and Pharmaceutical Compositions and Medical Uses Thereof | |
HUP0002836A2 (hu) | Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |